Rhodiosin |
Katalog-Nr.GC37528 |
Rhodiosin, isoliert aus der Wurzel von Rhodiola crenulata, ist ein spezifischer, nicht kompetitiver Cytochrom P450 2D6-Inhibitor mit einem IC50 von 0,420 μM und einem Ki von 0,535 μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 86831-54-1
Sample solution is provided at 25 µL, 10mM.
Rhodiosin, isolated from the root of Rhodiola crenulata, is a specific non-competitive cytochrome P450 2D6 inhibitor with an IC50 of 0.420 μM and a Ki of 0.535 μM[1]. Rhodiosin exhibits potent, dose-dependent inhibitory effects on acetylcholinesterase (AChE) with IC50 ranged from 57.50 to 2.43 μg/mL[2]. Rhodiosin exhibits potent DPPH free radical scavenging activities, with an IC50 of 27.77 μM[3]. IC50: 0.420 μM (cytochrome P450 2D6)[1];57.50-2.43 μg/mL (AChE)[2];27.77 μM (DPPH free radical scavenging)[3]
[1]. Xu W, et al. Two potent cytochrome P450 2D6 inhibitors found in Rhodiola rosea. Pharmazie. 2013 Dec;68(12):974-6. [2]. Li FJ, et al. Molecular interaction studies of acetylcholinesterase with potential acetylcholinesterase inhibitors from the root of Rhodiola crenulata using molecular docking and isothermal titration calorimetry methods. Int J Biol Macromol. 2017 Nov;104(Pt A):527-532. [3]. Choe KI, et al. The antioxidant and anti-inflammatory effects of phenolic compounds isolated from the root of Rhodiola sachalinensis A. BOR. Molecules. 2012 Sep 27;17(10):11484-94.
Average Rating: 5
(Based on Reviews and 29 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *